Procter & Gamble Company (The) $PG Stock Holdings Raised by Tectonic Advisors LLC

Key Points

• Tectonic Advisors LLC increased its holdings in Procter & Gamble by 11.3%, owning a total of 56,059 shares worth approximately $8.93 million.
• Insiders have been actively selling shares, with COO Shailesh Jejurikar selling 3,986 shares for roughly $606,789, representing a 7.83% decrease in his ownership.
• Analysts have mixed ratings for Procter & Gamble, with target prices ranging from $170.00 to $180.00 and an average "Moderate Buy" rating.

Tectonic Advisors LLC raised its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 11.3% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 56,059 shares of the company's stock after purchasing an additional 5,706 shares during the period. Tectonic Advisors LLC's holdings in Procter & Gamble were worth $8,931,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Nova Wealth Management Inc. bought a new stake in shares of Procter & Gamble during the 1st quarter valued at about $26,000. Signature Resources Capital Management LLC grew its position in shares of Procter & Gamble by 67.9% during the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after buying an additional 72 shares during the last quarter. Quarry LP bought a new stake in shares of Procter & Gamble during the 1st quarter valued at about $33,000. Mizuho Securities Co. Ltd. grew its position in shares of Procter & Gamble by 566.7% during the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after buying an additional 170 shares during the last quarter. Finally, RMG Wealth Management LLC bought a new stake in shares of Procter & Gamble during the 2nd quarter valued at about $37,000. Institutional investors own 65.77% of the company's stock.

Insider Buying and Selling

In related news, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the sale, the chief operating officer directly owned 46,899 shares of the company's stock, valued at $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Balaji Purushothaman sold 490 shares of the stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider directly owned 12,616 shares of the company's stock, valued at approximately $1,920,533.68. This represents a 3.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 149,763 shares of company stock worth $23,421,279. Company insiders own 0.20% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently weighed in on PG. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of Procter & Gamble in a research report on Wednesday. UBS Group reduced their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research note on Wednesday. JPMorgan Chase & Co. reissued a "neutral" rating and set a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Bank of America reduced their target price on shares of Procter & Gamble from $180.00 to $174.00 and set a "buy" rating for the company in a research note on Wednesday. Finally, BNP Paribas reissued an "outperform" rating and set a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. Eleven investment analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and an average target price of $172.58.

Procter & Gamble Trading Down 1.2%

Shares of NYSE:PG opened at $150.67 on Thursday. The company has a 50 day moving average of $155.26 and a 200-day moving average of $159.72. The firm has a market cap of $352.64 billion, a P/E ratio of 23.14, a P/E/G ratio of 4.05 and a beta of 0.36. Procter & Gamble Company has a twelve month low of $149.91 and a twelve month high of $180.43. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The company had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's revenue for the quarter was up 1.7% compared to the same quarter last year. During the same period in the prior year, the business posted $1.40 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

About Procter & Gamble

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.